Adjunctive Benefit of Electrolytic Cleaning on Non-surgical Treatment of Peri-implantitis.

June 22, 2022 updated by: Vanessa Rocha Rodrigues, University of Lisbon

Adjunctive Benefit of Electrolytic Cleaning on Non-surgical Treatment of Peri-implantitis. A 1-year Randomized Controlled Clinical Trial.

Evaluate the outcomes of non-surgical therapy of peri-implantitis with the adjunctive use of electrolytic cleaning (Galvo Surge®).

The proposed protocol, focused on the non-surgical treatment of peri-implantitis, will result in a higher percentage of subjects with disease resolution (probing depts ≤ 5mm, absence of BOP and/or SOP and no further bone loss) at 1 year of follow-up.

Study Overview

Detailed Description

The adjunctive use of electrolytic cleaning (Galvo Surge®) in the non-surgical treatment of peri-implantitis will result in a higher reduction of probing depth than the control group.

The adjunctive use of electrolytic cleaning (Galvo Surge®) in the non-surgical treatment of peri-implantitis will result in a higher radiographic bone fill of the peri-implant defect than the control group.

The adjunctive use of electrolytic cleaning (Galvo Surge®) in the non-surgical treatment of peri-implantitis will result in a lower count of peri-implant pathogens than the control group.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Partially edentulous patients, rehabilitated with at least one dental implant in the maxilla or mandible;
  2. Presence of Peri-implantitis;
  3. No implant mobility;
  4. Treated periodontal disease;
  5. No systemic diseases that could influence the outcome of the therapy (i.e. uncontrolled diabetes, osteoporosis, bisphosphonate medication).
  6. Non-smoker or light smoking status in smokers (<10 cigarettes/day).

Exclusion Criteria:

(1) Pregnant, lactating women and non-collaborating patients will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: With electrolytic cleaning
Mechanical debridement with ultrasonics (plastic tip) and plastic curettes
Implants are decontaminated with electrolytic cleaning
PLACEBO_COMPARATOR: Without electrolytic cleaning
Mechanical debridement with ultrasonics (plastic tip) and plastic curettes
Implants are decontaminated without electrolytic cleaning

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probing pocket depth
Time Frame: Assessing the change of probing pocket depth from baseline at 3 months, 6 months and 12 months
Will be calculated as the distance from the gingival peri-implant margin to the bottom of the peri-implant pocket (Mombelli & Lang, 1994).
Assessing the change of probing pocket depth from baseline at 3 months, 6 months and 12 months
Recession
Time Frame: Assessing the change of recession from baseline at 3 months, 6 months and 12 months
will be measured as the distance from the free marginal mucosa to the most apical portion of the crown.
Assessing the change of recession from baseline at 3 months, 6 months and 12 months
Clinical attachment level
Time Frame: Assessing the change from clinical attachment level from baseline at 3 months, 6 months and 12 months
will be calculated as the sum of PPD and REC (distance from the most apical portion of the crown to the bottom of the periodontal pocket)
Assessing the change from clinical attachment level from baseline at 3 months, 6 months and 12 months
Bleeding on probing
Time Frame: Assessing the change from bleeding on probing from baseline at 3 months, 6 months and 12 months
will be assessed dichotomously in six sites per implant (Heitz-Mayfield, 2008).
Assessing the change from bleeding on probing from baseline at 3 months, 6 months and 12 months
Radiographic Parameters
Time Frame: Assessing the change of the radiographic parameters from baseline at 3 months, 6 months
Radiographic analysis through orthopantomography, periapical intraoral radiographs according to the parallelometric technique (using a silicone bite record so that the radiographs are parallelized and comparable to each other in different timepoints, checking in millimeters the increase or decrease in bone loss).
Assessing the change of the radiographic parameters from baseline at 3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Microbiological Parameters
Time Frame: Assessing the change of the microbiological parameters from baseline at 3 months, 6 months
A sterilized paper tip from the microbiological kit will be introduced in the periimplantitis pocket, remaining in the same position for 10 seconds. After collecting the sample, the paper tip will be placed in an individual transfer tube, properly identified. Afterwards, the sample will be sent to the laboratory, where a polymerase chain reaction (PCR) test is performed to identify the following bacteria - A. actinomycetemcomitans, T. forsythia, T. denticola, P. gingivalis, P. intermedia and F. nucleatum.
Assessing the change of the microbiological parameters from baseline at 3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tiago Ribeiro-Amaral, Dr, University of Lisbon
  • Study Director: Paulo Macaranhas, PhD, University of Lisbon
  • Study Chair: Vanessa Rocha Rodrigues, Dr, University of Lisbon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

October 1, 2022

Primary Completion (ANTICIPATED)

September 1, 2023

Study Completion (ANTICIPATED)

September 1, 2024

Study Registration Dates

First Submitted

December 3, 2021

First Submitted That Met QC Criteria

December 16, 2021

First Posted (ACTUAL)

January 5, 2022

Study Record Updates

Last Update Posted (ACTUAL)

June 24, 2022

Last Update Submitted That Met QC Criteria

June 22, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Electrolytic cleaning

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peri-Implantitis

Clinical Trials on Implants are decontaminated with electrolytic cleaning

Subscribe